Tezspire meets primary endpoints in Phase III EoE trial CROSSINGAug 27Clinical readoutAmgenAstraZeneca
AstraZeneca posts MITCHELL asthma results; registers AZD6234 Phase 3 SELENE 2Aug 27Weekly roundup, 7 itemsAstraZenecaAZD4144
AstraZeneca posts PASSAGE Phase 4 tezepelumab results; registers new prostate, lung, and NF2 trialsJul 17Weekly roundup, 6 itemsAstraZenecaosimertinib
Sign inSign in